NYU Technology Opportunities & Ventures

🎁 If you're looking for some (very) last-minute gift ideas, check out the NYU Entrepreneurial Institute's Startup Holiday Gift Guide, a list of New York University startups (including nonprofits) founded by students and recent alumni that you can support this holiday season while spreading cheer with your loved ones! https://lnkd.in/er5Z3bx4

I want to highlight this project because it's the best example of what we do and the power of the changing face of tech transfer. Dr. Park had some very interesting findings but still needed some help creating more data to find a good partner. The project had support and funding from our internal Therapeutic Alliances program to focus on filling the data gap with an eye on what potential partners needed. Next, we considered doing a startup around the project so it went into our full due diligence mode where our investment analyst created our own models for future commercial applications. Based on these results, and working with our BD team, we extended some patent rights into the national phase in specific countries--an expensive decision we did not take lightly but we had enough data to think it was a worthy investment. Eventually the combination of internal investment, data generation, and active partnering efforts found Xentria, who saw the potential we saw in this innovation and will now take over driving the idea to market. There were at least 10 people on the NYU Technology Opportunities & Ventures staff who engaged in the commercialization process. Special shout-outs to Douglas Brawley, PhD, Keaton Crosse, PhD Gaspar Taroncher-Oldenburg, Kevin Sampson, Dilip Joseph, Sadhana Chitale, and Shilpa V. Patel (and others) who proved it takes a village to get good ideas where they need to be. Our work is not licensing. It's not IP. It's not about revenue. It's about getting great ideas out of the lab and into the market to improve the human condition by any means necessary. This ain't your grandfather's tech transfer but it's the work that needs doing now and in the future.

📢Exciting partnership news! TOV is thrilled to announce an exclusive licensing agreement with Xentria, Inc. to advance a potential disease-modifying therapeutic for cardiovascular disease from Dr. David Park's Lab at NYU Langone Health. Xentria is a clinical-stage biotherapeutics company focused on advancing drug development to address unmet medical needs. The company will have an exclusive worldwide license to use NYU's intellectual property in connection with the collaborative research and development and Xentria's clinical development and commercialization of the new therapeutic formulation, GL-12. This is an excellent example of how academic collaborations combine world-class biomedical research with drug development expertise to accelerate scientific breakthroughs and deliver much-needed therapies to patients. 📰 Read the press release: https://lnkd.in/gE--9F8m #academiccollaboration #drugdevelopment #cardiovasculardisease #biomedresearch #NYUInnovation #biotherapeutics

🎉 We are excited to share that NYU Langone Health's Dr. Bruce Cronstein has been elected to the National Academy of Inventors 2024 Class of Fellows. NAI Fellowship is the highest professional distinction awarded solely to inventors. Dr. Cronstein’s research on adenosine receptors has opened up avenues for finding cures for the suffering associated with inflammatory conditions in the body for millions of patients affected by such diseases. He has 11 issued U.S. patents and numerous foreign patents, a majority of which have been licensed by industry for the development of products to treat rheumatic conditions. He also co-founded the startup Regenosine to develop a novel therapy for Osteoarthritis. Congratulations Dr. Cronstein! Read more about the 2024 Fellows class: https://lnkd.in/exzqgf_Y #NYUInnovation #NYUResearch

Big Things Are Brewing for 2025! Founders, strategics and investors—get ready! The second annual Investor and Innovator Exchange, in partnership with NYU Technology Opportunities & Ventures is coming soon. Stay tuned for your chance to connect, pitch and drive the future of life sciences in #NYC #startups #ixi #research #lifesciences #biotech

The sun never sets on New York University research and innovation. It's always great to come to our campus in Abu Dhabi and see the sophisticated research programs and the inevitable licenses and startups that will arise from them. Plus it's 80F here while snowing in NYC, so double bonus.

A huge congratulations to Dr. Minh Tran, co-founder of New York University startup Heliotrope Photonics, who has been named to the Forbes 30 Under 30 list in the Manufacturing & Industry category🏆. Minh is hardworking, intelligent, and a dedicated founder and this is a well-deserved honor! Heliotrope's chemical coating converts ultraviolet light to infrared light (which is better absorbed by solar panels), boosting solar generation by up to 15%. Heliotrope was also just named NYU's Startup to Watch! https://lnkd.in/dgsiDSmW #Forbes30Under30

Last Thursday, New York University held its inaugural Innovators’ Dinner to recognize and encourage the commercialization of groundbreaking ideas developed through NYU research. Hosted by TOV and NYU’s Office of the Vice Provost for Research, the evening brought together leading university innovators and entrepreneurs, and members of the NYU community who support research translation. Together, they recognized the successful commercialization activity of 2024 from NYU’s campuses in Washington Square, Brooklyn, Abu Dhabi, and Shanghai, which led to a record number of innovation disclosures, licenses, and new startups based on NYU ideas. Congratulations to all the 2024 contributors who were honored, including first-time “disclosers” of innovations, innovators of licensed technology, and innovators on issued US patents. A highlight of the evening was the announcement and presentation of key university awards: 🏆 Innovator of the Year - Dr. Bhubaneswar Mishra (NYU Courant Institute of Mathematical Sciences) 🏆Startup to Watch - Heliotrope Photonics, Founders Dr. Minh Tran (NYU Tandon School of Engineering) and Conradin Caviezel (NYU Stern School of Business) 🏆Deal of the Year - Prescient Design, Founders Dr. KyungHyun Cho (NYU Courant Institute of Mathematical Sciences) and Dr. Richard Bonneau Learn more about the dinner and the honorees: https://lnkd.in/eERhExpD #NYUResearch #NYUInnovation Photos © Hollenshead: Courtesy of NYU Photo Bureau

The first CEO Circle for NYU life sciences spinouts took place yesterday evening. The founders gathered together to discuss their experiences and challenges, and to learn about resources and opportunities made available for life sciences companies through the New York City Economic Development Corporation (NYCEDC). We are grateful to Mikko Baylosis and Justina T. of the NYCEDC and Azade Hosseini from the NYU Entrepreneurial Institute for joining us and participating in this exciting meetup. #NYUStartups #NYUInnovation

A huge thank you to yesterday's IIRIS seminar speaker Rafail Tasakis, PhD, head of business development at Solvuu, for coming to campus to share his experience and advice with our audience. #NYUInnovation #NYUResearch #NYU_IIRIS